The new journal club for Tuesday is a study of atrasentan for diabetic kidney disease. When I wrote introduction post I went to wikipedia and learned that atrasentan had been in trials as an antineoplastic agent. I went to the Twitter and asked if anyone was using it.
He then gave me the keys to the kingdom by showing me where to search NCI site for trials. Bingo.
I was Quickly able to find the failed phase 3 trial and updated wikipedia.